Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Medicine

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.3267PMID 23921754PMCID PMC3967018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenicity of Pluripotent Stem Cells and Their Derivatives

  2013cited by this paper
• Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

  2013cited by this paper
• Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.

  2013cited by this paper
• Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen.

  2013cited by this paper
• WNT signaling determines tumorigenicity and function of ESC-derived retinal progenitors.

  2013cited by this paper
• Stem cells cruise to clinic

  2013cited by this paper
• Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.

  2013cited by this paper
• Pluripotent Stem Cells: Immune to the Immune System?

  2012cited by this paper
• The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.

  2012cited by this paper
• Prolonged Maturation Culture Favors a Reduction in the Tumorigenicity and the Dopaminergic Function of Human ESC‐Derived Neural Cells in a Primate Model of Parkinson's Disease

  2012cited by this paper
• Human Embryonic Stem Cells Fail to Activate CHK1 and Commit to Apoptosis in Response to DNA Replication Stress

  2012cited by this paper
• EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Deficient DNA Damage Response and Cell Cycle Checkpoints Lead to Accumulation of Point Mutations in Human Embryonic Stem Cells

  2012cited by this paper
• Embryonic stem cell trials for macular degeneration: a preliminary report.

  2012cited by this paper
• Transcriptional amplification in tumor cells with elevated c-Myc.

  2012cited by this paper
• Activation of innate immunity is required for efficient nuclear reprogramming.

  2012cited by this paper
• Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

  2011cited by this paper
• Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors

  2011cited by this paper
• Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells.

  2011cited by this paper
• SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells.

  2011cited by this paper
• Copy number variation and selection during reprogramming to pluripotency

  2011cited by this paper
• Immunogenicity of induced pluripotent stem cells

  2011cited by this paper
• An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells

  2011cited by this paper
• Inducible apoptosis as a safety switch for adoptive cell therapy.

  2011cited by this paper
• Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

  2011cited by this paper
• Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD

  2011cited by this paper
• Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

  2011cited by this paper
• The tumorigenicity of human embryonic and induced pluripotent stem cells

  2011cited by this paper
• Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.

  2011cited by this paper
• A nonviral minicircle vector for deriving human iPS cells

  2010cited by this paper
• Lab-specific gene expression signatures in pluripotent stem cells.

  2010cited by this paper
• A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs.

  2010cited by this paper
• Using small molecules to improve generation of induced pluripotent stem cells from somatic cells.

  2010cited by this paper
• Geron trial resumes, but standards for stem cell trials remain elusive

  2010cited by this paper
• Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.

  2010cited by this paper
• Identification and classification of chromosomal aberrations in human induced pluripotent stem cells.

  2010cited by this paper
• Strange lesions after stem-cell therapy

  2010cited by this paper
• High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity

  2010cited by this paper
• Promotion of direct reprogramming by transformation-deficient Myc

  2010cited by this paper
• Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

  2010cited by this paper
• Induced pluripotent stem cells generated without viral integration

  2009cited by this paper
• SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas

  2009cited by this paper
• Chromosome instability is common in human cleavage-stage embryos

  2009cited by this paper
• Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient

  2009cited by this paper
• Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors.

  2009cited by this paper
• piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

  2009cited by this paper
• Characterization of human embryonic stem cells with features of neoplastic progression

  2009cited by this paper
• Fits and starts for Geron

  2009cited by this paper
• Effects of cell number on teratoma formation by human embryonic stem cells

  2009cited by this paper
• Faculty Opinions recommendation of Human induced pluripotent stem cells free of vector and transgene sequences.

  2009cited by this paper
• Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences

  2009cited by this paper
• c-Myc is dispensable for direct reprogramming of mouse fibroblasts.

  2008cited by this paper
• An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated Without Viral Integration

  2008cited by this paper
• Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts

  2008cited by this paper
• Selection Against Undifferentiated Human Embryonic Stem Cells by a Cytotoxic Antibody Recognizing Podocalyxin‐Like Protein‐1

  2008cited by this paper
• Recurrent chromosomal abnormalities in human embryonic stem cells

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Reflecting on 25 years with MYC

  2008cited by this paper
• Transgenic Mice with Defined Combinations of Drug Inducible Reprogramming Factors

  2008cited by this paper
• Human embryonic stem cells reveal recurrent genomic instability at 20q11.21

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells

  2006cited by this paper
• Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes

  2006cited by this paper
• The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene

  2005cited by this paper
• Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

  2005cited by this paper
• Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

  2004cited by this paper
• Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells

  2004cited by this paper
• Induction of Tumors in Mice by Genomic Hypomethylation

  2003cited by this paper
• Characterization of the expression of MHC proteins in human embryonic stem cells

  2002cited by this paper
• Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy.

  2002cited by this paper
• Combined management of malignant teratoma of the testis.

  1979cited by this paper
• A Preliminary Report

  1953cited by this paper

• Comparing digital and real-time PCR platforms for detecting residual iPSCs and virus-producing cells in manufacturing.

  2026cites this paper
• A synthetic hyperglycemia-sensing gene circuit enhances blood glucose homeostasis in diabetic mice.

  2026cites this paper
• Stem cell-based therapies for silicosis: mechanisms, sources, clinical translation, and emerging strategies.

  2026cites this paper
• Blood Vessels Bioengineered from Induced Pluripotent Stem Cell Derived Mesenchymal Stem Cells and Functional Scaffolds

  2025cites this paper
• Trends and Considerations in Annulus Fibrosus In Vitro Model Design.

  2025cites this paper
• Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington’s disease phenotypes

  2025cites this paper
• Mammalian Blastema: Possibility and Potentials

  2025cites this paper
• Plant-Derived Vesicle-like Nanoparticles: Pioneering Sustainable and Effective Approaches for Tissue Repair and Regeneration

  2025cites this paper
• CAR-NK cells to treat patients with cancer: a systematic scoping review of published studies and registered clinical trials.

  2025cites this paper
• Human stem cells with in vivo high plasticity generated by cell–cell communication

  2025cites this paper
• Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy

  2025cites this paper
• Addressing the challenges of immunogenicity, heterogeneity and tumorigenicity in the clinical translation of human embryonic stem cells

  2025influential citation
• Single-cell dissection of cell hierarchies in urine-derived stem cells – application to chondrogenesis and general scalability

  2025cites this paper
• Uncovering the Healing Power of Stem Cells: Harnessing Regenerative Therapies for Alzheimer's Disease.

  2025cites this paper
• Advances in GABAergic Progenitor Cells Transplantation for Drug-Resistant Epilepsy

  2025cites this paper
• CD9-enriched extracellular vesicles from chemically reprogrammed basal progenitors of salivary glands mitigate salivary gland fibrosis

  2025cites this paper
• Bioreactors expansion of human mesenchymal stromal cell therapies: platforms, parameters, challenges and opportunities

  2025cites this paper
• Assessing mesh size and diffusion of alginate bioinks: A crucial factor for successful bioprinting functional pancreatic islets

  2025cites this paper
• Carcinogenicity And Oncogenicity of Precursor/Progenitor Stem Cells of the Xenogeneic Origin: The Balb/C-3t3 Cell Transformation Assay

  2025cites this paper
• Pharmacological modulation of stem cells signaling pathway for therapeutic applications

  2025cites this paper
• Transcription Factor‐Based Gene Therapy Enables Functional Repair of Rat Following Chronic Ischemic Stroke

  2025cites this paper
• Skeletal Muscle Tissue Engineering: From Tissue Regeneration to Biorobotics

  2025cites this paper
• Stem Cell Therapy for Diseases of Livestock Animals: An In-Depth Review

  2025cites this paper
• Functional recovery by transplantation of human iPSC-derived A2B5 positive neural progenitor cell after spinal cord injury in mice

  2025cites this paper
• Chemistry, Manufacturing and Controls Considerations for Tumorigenicity and Oncogenicity on Cellular Therapy Products

  2025cites this paper
• Single-cell glycome and transcriptome profiling uncovers the glycan signature of each cell subpopulation of human iPSC-derived neurons

  2025cites this paper
• Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?

  2025cites this paper
• The emerging promise of induced pluripotent stem cells in clinical studies: a systematic scoping review of the literature and registered clinical trials.

  2025cites this paper
• Teratoma-free cartilage regeneration using p21−/− iPSCs engineered with iCasp9

  2025cites this paper
• The Effect of Stem Cell Secretome on the Improvement of Diabetic Wound Recovery: A Systematic Review and Meta-Analysis of In Vivo Studies

  2025cites this paper
• Deciphering of the reactive oxygen species (ROS) induced calpain activation in cancer progression and its therapeutic potential

  2025cites this paper
• In silico chemical fingerprint screening identifies fisetin as a novel stemotoxic flavonoid.

  2025cites this paper
• Ngn2 and Isl1-mediated astrocyte-to-neuron conversion in vivo promotes functional recovery after spinal cord injury

  2025cites this paper
• Deer antler ASCs exosomes ameliorate osteoarthritis via miR-140/MMP13 axis-mediated dual modulation of inflammation and cartilage regeneration

  2025cites this paper
• Glycosphingolipids in neurodegeneration - Molecular mechanisms, cellular roles, and therapeutic perspectives.

  2025cites this paper
• The Yin and Yang of Cellular Senescence in Ischemia-Induced Myocardial Injury.

  2025cites this paper
• Advances in Stem Cell Therapies for Ocular Diseases: Progress in Clinical Trials and Future Perspectives

  2025cites this paper
• Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges

  2025cites this paper
• Blood vessels bioengineered from induced pluripotent stem cell derived mesenchymal stem cells and porous silk fibroin coated functional scaffolds

  2025cites this paper
• Stem Cell-Based Approaches for Spinal Cord Injury: The Promise of iPSCs

  2025cites this paper
• Advances in Islet Function Replacing Strategies After Total Pancreatectomy.

  2025cites this paper
• Telomerase Dynamics in Stem Cells: Unraveling the Molecular Nexus of Cellular Aging and Regeneration.

  2025cites this paper
• Elimination of tumorigenic pluripotent stem cells from their differentiated cell therapy products: An important step toward ensuring safe cell therapy

  2025cites this paper
• Proneurogenic Actions of FSH During Directed Differentiation of Neural Stem and Progenitor Cells from Ovarian Cortical Cells Towards the Dopaminergic Pathway

  2025cites this paper
• Single-cell transcriptomics identifies chondrocyte differentiation dynamics in vivo and in vitro.

  2025cites this paper
• Considerations in biodistribution evaluation of iPSC-derived cell therapy: A pancreatic islet cell case study

  2025cites this paper
• Microneedle-mediated exosome delivery: a precision strategy in advanced regenerative medicine.

  2025cites this paper
• Targeted delivery of engineered adipose-derived stem cell secretome to promote cardiac repair after myocardial infarction

  2025cites this paper
• The road to restore male fertility using in vitro-derived germ cells.

  2025cites this paper
• Cell-engineered technologies for wound healing and tissue regeneration

  2025cites this paper
• Current challenges and future directions of ATMPs in regenerative medicine

  2025cites this paper
• High-precision in vivo tracking of stem cells using carbon-14 labeling: a novel quantitative approach for assessing therapeutic efficacy and safety

  2025cites this paper
• Engineering the next generation of allogeneic CAR cells: iPSCs as a scalable and editable platform

  2025cites this paper
• Current advances and future prospects of cell reprogramming in progeroid syndromes

  2025cites this paper
• Stem cell-derived extracellular vesicles as a therapeutic for avascular necrosis: current status and future prospects.

  2025cites this paper
• Enhancing Cardiomyocyte Purity through Lactate-Based Metabolic Selection

  2025cites this paper
• Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice

  2025cites this paper
• Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment

  2025cites this paper
• Innovative approaches to boost mesenchymal stem cells efficacy in myocardial infarction therapy

  2025cites this paper
• An off‐the‐Shelf Injectable MSC Hydrogel with Microenvironment‐Driven Responsiveness for Precision Osteoarthritis Treatment

  2025cites this paper
• Extracellular Vesicles in Cardiovascular Diseases: Signaling, Biomarker, and Therapy

  2025cites this paper
• Clinical trials and advanced MRI techniques with stem cell therapy for ischemic stroke: present and future perspectives

  2025cites this paper
• Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma

  2025cites this paper
• Immortalization of Mesenchymal Stem Cells for Application in Regenerative Medicine and Their Potential Risks of Tumorigenesis

  2024cites this paper
• Using magnetic resonance relaxometry to evaluate the safety and quality of induced pluripotent stem cell-derived spinal cord progenitor cells

  2024cites this paper
• Reprogramming induced neurons from olfactory ensheathing glial cells: A feasible approach for spinal cord injury repair

  2024cites this paper
• Human embryonic stem cell spheroids derived exosomal hsa_circ_0003258 sequestered dual targeting of miR-502-5p on KLF4/NF-κB and GALNT4/P53 to mitigate inflammation and apoptosis in hepatic ischemia reperfusion injury

  2024cites this paper
• Spheroid-Exosome-Based Bioprinting Technology in Regenerative Medicine

  2024cites this paper
• Narrative review of proximal tubular epithelial cell in-vitro co-culture models

  2024cites this paper
• Advances in liver engineering with cell, scaffold, and vascularization

  2024cites this paper
• Isolation, identification, and challenges of extracellular vesicles: emerging players in clinical applications

  2024cites this paper
• Human studies of the efficacy and safety of stem cells in the treatment of diabetic peripheral neuropathy: a systematic review and meta-analysis

  2024cites this paper
• Mesenchymal stromal cells-derived small extracellular vesicles protect against UV-induced photoaging via regulating pregnancy zone protein

  2024cites this paper
• A tumorigenicity evaluation platform for cell therapies based on brain organoids

  2024cites this paper
• Induced pluripotent stem cell therapies in heart failure treatment: a meta-analysis and systematic review.

  2024cites this paper
• Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine

  2024cites this paper
• Human iPSC-derived neural stem cells displaying radial glia signature exhibit long-term safety in mice

  2024cites this paper
• Selective Elimination of Genetic Variants of Human Embryonic Stem Cells from High Vulnerability to Ferroptosis

  2024cites this paper
• Stem cell therapy in Alzheimer’s disease: current status and perspectives

  2024cites this paper
• Regenerative mechanisms of stem cells and their clinical applications for degenerative eye diseases

  2024cites this paper
• Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives

  2024cites this paper
• Hybrid nanovesicles comprising induced pluripotent stem cells and dendritic cell-derived exosomes enhance antitumor immunity

  2024cites this paper
• Mechanism and application of mesenchymal stem cells and their secreting extracellular vesicles in regulating CD4+T cells in immune diseases

  2024cites this paper
• Deciphering the heterogeneity of differentiating hPSC-derived corneal limbal stem cells through single-cell RNA sequencing

  2024cites this paper
• From stem cells to regulatory T cells: A tale of plasticity.

  2024cites this paper
• A promise for neuronal repair: reprogramming astrocytes into neurons in vivo

  2024cites this paper
• Label‐Free Impedance Analysis of Induced Pluripotent Stem Cell‐Derived Spinal Cord Progenitor Cells for Rapid Safety and Efficacy Profiling

  2024cites this paper
• Novel insights into the potential applications of stem cells in pulmonary hypertension therapy

  2024cites this paper
• Strategies for modeling aging and age-related diseases

  2024cites this paper
• Novel Treatment for Parkinson’s Disease with Intravenous Allogeneic Pluripotent Non-Tumorigenic Adipose Stem Cell Transplantation: A Case Report

  2024cites this paper
• Advances in human pluripotent stem cell reporter systems

  2024cites this paper
• Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

  2024cites this paper
• Development and characterization of a first-in-class adjustable-dose gene therapy system.

  2024cites this paper
• Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.

  2024cites this paper
• Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations

  2024cites this paper
• 4D bioprinting of programmed dynamic tissues

  2024cites this paper
• Current Advances in Mesenchymal Stem Cell Therapies Applied to Wounds and Skin, Eye, and Neuromuscular Diseases in Companion Animals

  2024cites this paper
• Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications

  2024cites this paper
• Engineered extracellular vesicle-based gene therapy for the treatment of discogenic back pain

  2024cites this paper
• Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells

  2024cites this paper